NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $980,000 | -29.0% | 74,953 | -30.4% | 0.26% | -29.8% |
Q2 2022 | $1,380,000 | -16.0% | 107,653 | 0.0% | 0.38% | -12.1% |
Q1 2022 | $1,642,000 | +15.2% | 107,653 | +33.8% | 0.43% | +19.6% |
Q4 2021 | $1,425,000 | +3.6% | 80,485 | +22.9% | 0.36% | -1.9% |
Q3 2021 | $1,376,000 | +129.0% | 65,485 | +114.7% | 0.36% | +189.7% |
Q2 2021 | $601,000 | +106.5% | 30,502 | +205.0% | 0.13% | +82.6% |
Q1 2021 | $291,000 | +216.3% | 10,000 | +59.6% | 0.07% | +97.1% |
Q2 2019 | $92,000 | – | 6,265 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |